Sudarshan Pharma shares surged nearly 4% to ₹20.25 after reporting Q3FY26 revenue of ₹158.37 crore, a 37% YoY increase. Net profit rose 56% to ₹43.05 crore. Despite a 27.40% drop in January, the stock shows a strong long-term gain of 165%.